Phreesia, Inc. (NYSE:PHR) SVP Sells $17,209.60 in Stock

Phreesia, Inc. (NYSE:PHR) SVP Amy Beth Vanduyn sold 640 shares of the stock in a transaction on Thursday, July 17th. The stock was sold at an average price of $26.89, for a total transaction of $17,209.60. Following the sale, the senior vice president directly owned 129,180 shares of the company’s stock, valued at $3,473,650.20. This represents a 0.49% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink.

Phreesia Stock Up 3.3%

Shares of NYSE PHR opened at $27.68 on Thursday. The company has a market capitalization of $1.65 billion, a P/E ratio of -37.40 and a beta of 0.72. Phreesia, Inc. has a 52-week low of $17.07 and a 52-week high of $30.53. The company has a debt-to-equity ratio of 0.02, a quick ratio of 1.95 and a current ratio of 1.95. The company’s 50 day moving average price is $26.55 and its 200-day moving average price is $26.42.

Phreesia (NYSE:PHR) last released its earnings results on Wednesday, May 28th. The company reported ($0.07) earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($0.13) by $0.06. The company had revenue of $115.94 million for the quarter, compared to the consensus estimate of $115.00 million. Phreesia had a negative net margin of 9.83% and a negative return on equity of 16.23%. Phreesia’s quarterly revenue was up 14.5% compared to the same quarter last year. During the same quarter in the previous year, the company earned ($0.05) EPS. Equities analysts forecast that Phreesia, Inc. will post -1.1 earnings per share for the current year.

Hedge Funds Weigh In On Phreesia

Institutional investors have recently added to or reduced their stakes in the stock. Johnson Financial Group Inc. lifted its holdings in Phreesia by 381.3% during the fourth quarter. Johnson Financial Group Inc. now owns 1,131 shares of the company’s stock valued at $28,000 after purchasing an additional 896 shares during the last quarter. Quarry LP lifted its holdings in Phreesia by 210.9% during the fourth quarter. Quarry LP now owns 2,835 shares of the company’s stock valued at $71,000 after purchasing an additional 1,923 shares during the last quarter. KBC Group NV purchased a new stake in shares of Phreesia in the first quarter worth about $74,000. Farther Finance Advisors LLC lifted its holdings in shares of Phreesia by 9,375.0% in the second quarter. Farther Finance Advisors LLC now owns 3,032 shares of the company’s stock worth $86,000 after buying an additional 3,000 shares in the last quarter. Finally, CWM LLC lifted its holdings in shares of Phreesia by 994.9% in the first quarter. CWM LLC now owns 4,040 shares of the company’s stock worth $103,000 after buying an additional 3,671 shares in the last quarter. Institutional investors own 92.10% of the company’s stock.

Wall Street Analyst Weigh In

A number of analysts have commented on the stock. Wall Street Zen upgraded shares of Phreesia from a “hold” rating to a “buy” rating in a research note on Sunday, June 1st. KeyCorp raised their target price on shares of Phreesia from $28.00 to $35.00 and gave the stock an “overweight” rating in a research note on Monday, July 14th. Citigroup restated a “buy” rating on shares of Phreesia in a research note on Wednesday, May 28th. Truist Financial raised their target price on shares of Phreesia from $34.00 to $35.00 and gave the stock a “buy” rating in a research note on Thursday, May 29th. Finally, DA Davidson upgraded shares of Phreesia to a “strong-buy” rating in a research note on Tuesday. Eleven research analysts have rated the stock with a buy rating and one has assigned a strong buy rating to the stock. Based on data from MarketBeat.com, the stock presently has an average rating of “Buy” and a consensus price target of $32.27.

About Phreesia

Phreesia, Inc provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. The company offers access solutions that offers appointment scheduling system for online appointments, reminders, and referral tracking management; registration solution to automate patient self-registration; revenue cycle solution, which offer insurance-verification processes, point-of-sale payments applications, post-visit payment collection, and flexible payment options; and network connect solution to deliver clinically relevant content to patients.